YAP1::NR4A3 and YAP1::NCOA2 fusions in poroma: expanding the spectrum of molecular alterations in poroid tumors
Status In-Process Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články
PubMed
39222124
DOI
10.1007/s00428-024-03898-2
PII: 10.1007/s00428-024-03898-2
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Biologie Des Infections À Polyomavirus Team UMR1282 INRAE University of Tours Tours France
CARADERM French Network of Rare Cutaneous Cancer Lille France
Department of Dermatology AZ Groeninge Kortrijk Kortrijk Belgium
Department of Pathology AZ Groeninge B 1200 Kortrijk Belgium
Department of Pathology Cliniques Universitaires Saint Luc B 1200 Brussels Belgium
Department of Pathology Faculty of Medicine in Plzen Charles University Prague Czech Republic
Department of Pathology University Hospital of Nantes Nantes University Nantes France
Department of Pathology University Hospital of Tours 37044 Tours Cedex 09 France
Immunology and New Concepts in ImmunoTherapy Inserm CNRS UMR 1302 EMR6001 Nantes France
Zobrazit více v PubMed
Kervarrec T, Pissaloux D, Tirode F et al (2024) Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: an update. Histopathology 84:266–278 PubMed DOI
Kervarrec T, Sohier P, Pissaloux D et al (2023) Genetics of adnexal tumors: an update. Ann Dermatol Venereol 150:202–207 PubMed DOI
Kervarrec T, Pissaloux D, Paindavoine S et al (2023) Recurrent PAK2 rearrangements in poroma with folliculo-sebaceous differentiation. Histopathology 83:310–319 PubMed DOI
Robson A, Greene J, Ansari N et al (2001) Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases. Am J Surg Pathol 25:710–720 PubMed DOI
Sekine S, Kiyono T, Ryo E et al (2019) Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma. J Clin Invest 129:3827–3832 PubMed DOI PMC
Macagno N, Kervarrec T, Sohier P et al (2021) NUT is a specific immunohistochemical marker for the diagnosis of YAP1-NUTM1-rearranged cutaneous poroid neoplasms. Am J Surg Pathol 45(9):1221–7 PubMed DOI
Li P, Busam KJ (2023) Spindle cell porocarcinoma with a novel YAP1::MAML3 fusion. J Cutan Pathol 51:226–229 PubMed DOI
Watson S, LaVigne CA, Xu L et al (2023) VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesis. Cell Rep 42:112013 PubMed DOI PMC
Lee DY, Brayer KJ, Mitani Y et al (2020) Oncogenic orphan nuclear receptor NR4A3 interacts and cooperates with MYB in acinic cell carcinoma. Cancers 12:2433 PubMed DOI PMC
Wilbur HC, Robinson DR, Wu Y-M et al (2022) Identification of novel PGR-NR4A3 fusion in extraskeletal myxoid chondrosarcoma and resultant patient benefit from tamoxifen therapy. JCO Precis Oncol 6:e2200039 PubMed DOI PMC
Momeni-Boroujeni A, Mullaney K, DiNapoli SE et al (2024) Expanding the spectrum of NR4A3 fusion-positive gynecologic leiomyosarcomas. Mod Pathol Off J U S Can Acad Pathol Inc 37:100474
Safe S, Karki K (2021) The paradoxical roles of orphan nuclear receptor 4A (NR4A) in cancer. Mol Cancer Res MCR 19:180–191 PubMed DOI
Lee C-H, Kao Y-C, Lee W-R et al (2019) Clinicopathologic characterization of GREB1-rearranged uterine sarcomas with variable sex-cord differentiation. Am J Surg Pathol 43:928–942 PubMed DOI
Ito K, Ansai S-I, Fukumoto T et al (2017) Clinicopathological analysis of 384 cases of poroid neoplasms including 98 cases of apocrine type cases. J Dermatol 44:327–334 PubMed DOI
Kervarrec T, Westphal D, Pissaloux D et al (2024) Porocarcinomas with PAK1/2/3 fusions: a series of 12 cases. Histopathology
